BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3810487)

  • 1. Successful use of the Denver peritoneovenous shunt in patients with nephrogenic ascites.
    Hobar PC; Turner WW; Valentine RJ
    Surgery; 1987 Feb; 101(2):161-4. PubMed ID: 3810487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic improvement after peritoneovenous shunting in nephrogenic ascites.
    Morgan AG; Sivapragasam S; Fletcher P; Terry SI
    South Med J; 1982 Mar; 75(3):373-4. PubMed ID: 7063919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of refractory ascites in hemodialysis patient with peritoneovenous shunt (Denver shunt).
    Giannone G; Glabman S; Burrows L; Schanzer H
    Mt Sinai J Med; 1983; 50(3):256-7. PubMed ID: 6604871
    [No Abstract]   [Full Text] [Related]  

  • 4. Implantation of a Denver shunt by left subclavian approach for preventing kinking.
    Oida T; Mimatsu K; Kawasaki A; Kanou H; Kuboi Y; Matsuoka S; Amano S
    Hepatogastroenterology; 2009; 56(93):1074-7. PubMed ID: 19760944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short- and long-term effectiveness, morbidity, and mortality of peritoneovenous shunt inserted to treat massive refractory ascites of nephrogenic origin analysis of 14 cases.
    Holm A; Rutsky EA; Aldrete JS
    Am Surg; 1989 Nov; 55(11):645-52. PubMed ID: 2479308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritoneovenous shunting for malignant ascites.
    Wickremesekera SK; Stubbs RS
    N Z Med J; 1997 Feb; 110(1037):33-5. PubMed ID: 9066565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Successful treatment for intractable ascites with uterine cancer using double Denver peritoneovenous shunt system].
    Kawamoto J; Kimura F; Shimizu H; Yoshidome H; Ohtsuka M; Kato A; Yoshitomi H; Nozawa S; Furukawa K; Mitsuhashi N; Takeuchi D; Suda K; Yoshioka I; Miyazaki M
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1919-23. PubMed ID: 17212147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dialytic ascites: pathogenetic aspects and the possibilities of its treatment].
    Ermolenko VM; Klepikov PV
    Ter Arkh; 1988; 60(6):48-51. PubMed ID: 3206369
    [No Abstract]   [Full Text] [Related]  

  • 9. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites.
    Ginès P; Arroyo V; Vargas V; Planas R; Casafont F; Panés J; Hoyos M; Viladomiu L; Rimola A; Morillas R
    N Engl J Med; 1991 Sep; 325(12):829-35. PubMed ID: 1875966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritoneovenous shunts for malignant ascites.
    Sonnenfeld T; Tydén G
    Acta Chir Scand; 1986 Feb; 152():117-21. PubMed ID: 3953206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneovenous shunting for intractable ascites.
    Tyden G; Samnegård H; Thulin L
    Acta Chir Scand; 1982; 148(7):597-600. PubMed ID: 7168289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palliative treatment of malignant refractory ascites by positioning of Denver peritoneovenous shunt.
    Zanon C; Grosso M; Aprà F; Clara R; Bortolini M; Quaglino F; Cornaglia S; Simone P
    Tumori; 2002; 88(2):123-7. PubMed ID: 12088251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient selection and survival after peritoneovenous shunting for nonmalignant ascites.
    Smith RE; Nostrant TT; Eckhauser FE; Wilson JP; Knol JA; Strodel WE
    Am J Gastroenterol; 1984 Aug; 79(8):659-62. PubMed ID: 6465114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneovenous shunting for intractable ascites.
    Gullstrand P; Alwmark A; Börjesson B; Joelsson B; Bengmark S
    Scand J Gastroenterol; 1982 Nov; 17(8):1009-12. PubMed ID: 7167735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Denver type for peritoneovenous shunting of malignant ascites.
    Roussel JG; Kroon BB; Hart GA
    Surg Gynecol Obstet; 1986 Mar; 162(3):235-40. PubMed ID: 2420017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritoneovenous shunt for intractable ascites of hepatic, nephrogenic, and malignant causes.
    Holm A; Halpern NB; Aldrete JS
    Am J Surg; 1989 Aug; 158(2):162-6. PubMed ID: 2757146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peritoneal venous shunting for ascites: a 15-year perspective.
    Hyde GL; Dillon M; Bivins BA
    Am Surg; 1982 Mar; 48(3):123-7. PubMed ID: 7073133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneo-venous shunting in patients with cirrhotic ascites and end-stage renal failure.
    Gandhi VC; Leehey DJ; Stanley MM; Nemchausky BA; Daugirdas JT; Greenlee HB; Jablokow VR; Ing TS
    Am J Kidney Dis; 1985 Sep; 6(3):185-7. PubMed ID: 4036962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ascites in a patient undergoing maintenance hemodialysis.
    Kes P; Ratković-Gusić I; Sefer S
    Acta Med Croatica; 1997; 51(1):57-61. PubMed ID: 9115105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritoneovenous shunting is an effective treatment for intractable ascites.
    Sooriakumaran P; McAndrew HF; Kiely EM; Spitz L; Pierro A
    Postgrad Med J; 2005 Apr; 81(954):259-61. PubMed ID: 15811892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.